Hydroxychloroquine for chronic myeloid leukemia: complete cure on the horizon?

Expert Rev Hematol. 2011 Aug;4(4):369-71. doi: 10.1586/ehm.11.34.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Benzamides
  • Clinical Trials, Phase II as Topic
  • Female
  • Humans
  • Hydroxychloroquine / administration & dosage
  • Hydroxychloroquine / therapeutic use*
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Piperazines / administration & dosage
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / administration & dosage
  • Randomized Controlled Trials as Topic

Substances

  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Hydroxychloroquine
  • Imatinib Mesylate